Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Microneedling helps reduce hair-pulling and promotes hair regrowth in trichotillomania patients.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

The combined therapy of microneedling and light therapy effectively and safely promotes hair regrowth in trichotillomania.

Onabotulinum toxin A may help treat trichotillomania and promote hair growth.

Using tretinoin with triamcinolone acetonide helps treat alopecia areata.

Mesotherapy involves injecting substances like dutasteride, minoxidil, and vitamins into the skin to treat hair loss and skin conditions, with good patient satisfaction but possible skin inflammation.

A woman lost vision in one eye after a forehead injection, but prompt treatment led to partial vision recovery.

Microneedling with Triamcinolone acetonide is an effective, less invasive, and safe alternative to direct injections for treating alopecia areata.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Mesotherapy uses small injections to improve skin, reduce fat, and treat hair loss effectively and quickly.

Trichotillomania was successfully treated with risperidone and naltrexone.

Both treatments help hair regrowth, but Botulinum Toxin-A has fewer side effects.

The 755-nm alexandrite laser effectively and quickly treats trichostasis spinulosa with minimal pain and no side effects.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Group behavior therapy reduces hair-pulling symptoms more than supportive therapy but has limited long-term effectiveness.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

Injectable platelet-rich fibrin is better than platelet-rich plasma for promoting hair growth.

PRP injections improve periorbital wrinkles and show promise as a treatment.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.